share_log

Earnings Report: Quaker Chemical Corporation Missed Revenue Estimates By 5.0%

Earnings Report: Quaker Chemical Corporation Missed Revenue Estimates By 5.0%

收益報告:貴格克化學公司未達到收入預期5.0%
Simply Wall St ·  05/07 03:20

Quaker Chemical Corporation (NYSE:KWR) shareholders are probably feeling a little disappointed, since its shares fell 2.5% to US$186 in the week after its latest first-quarter results.       Quaker Chemical missed revenue estimates by 5.0%, coming in atUS$470m, although statutory earnings per share (EPS) of US$1.96 beat expectations, coming in 4.5% ahead of analyst estimates.     This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business.  With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

貴格化學公司(紐約證券交易所代碼:KWR)的股東可能會感到有些失望,因爲其股價在公佈最新的第一季度業績後的一週內下跌了2.5%,至186美元。儘管法定每股收益(EPS)爲1.96美元,超出預期,比分析師的預期高出4.5%,但貴格化學的收入未達到5.0%,爲4.7億美元。對於投資者來說,這是一個重要時刻,因爲他們可以在報告中追蹤公司的業績,看看專家對明年的預測,看看對該業務的預期是否有任何變化。考慮到這一點,我們收集了最新的法定預測,以了解分析師對明年的預期。

NYSE:KWR Earnings and Revenue Growth May 6th 2024

紐約證券交易所:KWR 收益和收入增長 2024 年 5 月 6 日

Taking into account the latest results, the consensus forecast from Quaker Chemical's six analysts is for revenues of US$1.97b in 2024. This reflects a satisfactory 2.3% improvement in revenue compared to the last 12 months.       Statutory earnings per share are predicted to soar 31% to US$8.56.        Yet prior to the latest earnings, the analysts had been anticipated revenues of US$2.00b and earnings per share (EPS) of US$8.48 in 2024.        The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.    

考慮到最新業績,貴格化學的六位分析師的共識預測是,2024年的收入爲19.7億美元。這反映出與過去12個月相比,收入增長了令人滿意的2.3%。預計每股法定收益將飆升31%,至8.56美元。然而,在最新業績公佈之前,分析師曾預計2024年的收入爲20億美元,每股收益(EPS)爲8.48美元。鑑於他們的估計沒有重大變化,共識分析師似乎沒有在這些結果中看到任何會改變他們對業務看法的內容。

It will come as no surprise then, to learn that the consensus price target is largely unchanged at US$234.        There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business.   The most optimistic Quaker Chemical analyst has a price target of US$280 per share, while the most pessimistic values it at US$222.   The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.    

因此,得知共識目標股價基本保持不變爲234美元也就不足爲奇了。但是,還有另一種思考價格目標的方法,那就是研究分析師提出的價格目標範圍,因爲範圍廣泛的估計可能表明,對業務可能的結果有不同的看法。最樂觀的貴格化學分析師將目標股價定爲每股280美元,而最悲觀的分析師則將其估值爲222美元。估計值的狹窄差異可能表明該業務的未來相對容易估值,或者分析師對其前景有強烈的看法。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that Quaker Chemical's revenue growth is expected to slow, with the forecast 3.1% annualised growth rate until the end of 2024 being well below the historical 15% p.a. growth over the last five years.    Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 4.8% annually.  So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Quaker Chemical.    

我們可以從大局的角度看待這些估計值的另一種方式,例如預測如何與過去的表現相提並論,以及預測相對於業內其他公司是否或多或少看漲。我們要強調的是,貴格化學的收入增長預計將放緩,預計到2024年底的年化增長率爲3.1%,遠低於過去五年15%的歷史年增長率。相比之下,該行業的其他公司(根據分析師的預測),後者的總體收入預計每年將增長4.8%。因此,很明顯,儘管收入增長預計將放緩,但整個行業的增長速度預計也將超過貴格克化學。

The Bottom Line

底線

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates.        On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry.       The consensus price target held steady at US$234, with the latest estimates not enough to have an impact on their price targets.  

最明顯的結論是,該業務的前景最近沒有重大變化,分析師的收益預測保持穩定,與先前的估計一致。從好的方面來看,收入估計沒有重大變化;儘管預測表明它們的表現將比整個行業差。共識目標股價穩定在234美元,最新估計不足以對其目標股價產生影響。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year.   We have forecasts for Quaker Chemical going out to 2026, and you can see them free on our platform here.

話雖如此,公司收益的長期軌跡比明年重要得多。我們對貴格化學的預測將持續到2026年,你可以在我們的平台上免費查看。

We don't want to rain on the parade too much, but we did also find 1 warning sign for Quaker Chemical that you need to be mindful of.  

我們不想在遊行隊伍中下太多雨,但我們也找到了貴格化學的一個警告標誌,你需要注意。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論